| Literature DB >> 28243177 |
Natasa Radosavljevic1, Dejan Nikolic2, Milica Lazovic1, Marija Hrkovic3, Olivera Ilic-Stojanovic1.
Abstract
OBJECTIVE: To analyze the impact of rehabilitation treatment on social functioning in elderly patients after hip fracture during a rehabilitation program.Entities:
Keywords: Elderly; Follow-up studies; Hip fracture; Rehabilitation
Year: 2016 PMID: 28243177 PMCID: PMC5035695 DOI: 10.1590/1413-785220162404156874
Source DB: PubMed Journal: Acta Ortop Bras ISSN: 1413-7852 Impact factor: 0.513
SF-36 SFC mean values in different time of observation for separate CIRS-G parameters regarding severity degree.
| Evaluated groups | CIRS-G (degree) | Musculoskeletal impairment | Neurological impairment | Cognitive impairment | p value |
|---|---|---|---|---|---|
| Group 1 (MV ± SD) | 0 | 28.07 ± 13.15 | 28.13 ± 14.66 | 30.16 ± 14.06 | 0.474* |
| 1 | 26.13 ± 16.39 | 27.21 ± 14.81 | 26.88 ± 14.86 | 0.952* | |
| 2 | 24.93 ± 13.51 | 20.54 ± 13.52 | 21.31 ± 11.74 | 0.417* | |
| 3 | 24.91 ± 14.18 | 20.59 ± 12.45 | 18.75 ± 10.72 | 0.249* | |
| 4 | - | 13.75 ± 7.56 | 9.10 ± 12.03 | 0.267** | |
| Group 2 (MV ± SD) | 0 | 51.60 ± 13.98 | 50.29 ± 15.90 | 53.06 ± 14.33 | 0.345* |
| 1 | 48.67 ± 18.40 | 50.00 ± 17.68 | 48.75 ± 17.40 | 0.962* | |
| 2 | 46.28 ± 14.98 | 46.43 ± 15.06 | 43.75 ± 14.68 | 0.774* | |
| 3 | 44.40 ± 14.79 | 42.29 ± 12.78 | 37.50 ± 12.86 | 0.253* | |
| 4 | - | 29.69 ± 11.45 | 30.30 ± 14.59 | 0.968** | |
| Group 3 (MV ± SD) | 0 | 64.96 ± 18.16 | 63.28 ± 20.16 | 67.34 ± 17.04 | 0.232* |
| 1 | 58.50 ± 23.63 | 61.77 ± 21.41 | 60.31 ± 20.19 | 0.828 | |
| 2 | 59.60 ± 19.58 | 51.79 ± 23.44 | 54.21 ± 22.80 | 0.422* | |
| 3 | 56.71 ± 21.56 | 52.21 ± 20.84 | 45.83 ± 18.69 | 0.221* | |
| 4 | - | 37.50 ± 16.37 | 27.80 ± 19.35 | 0.230** | |
| Group 4 (MV ± SD) | 0 | 75.11 ± 21.95 | 72.80 ± 23.96 | 77.47 ± 19.86 | 0.252* |
| 1 | 64.63 ± 27.71 | 63.24 ± 27.41 | 69.06 ± 22.64 | 0.630* | |
| 2 | 69.79 ± 25.13 | 56.21 ± 28.02 | 57.69 ± 31.04 | 0.143* | |
| 3 | 59.57 ± 26.96 | 57.35 ± 25.79 | 45.14 ± 21.07 | 0.153* | |
| 4 | - | 34.38 ± 17.36 | 29.45 ± 22.07 | 0.478** |
*Oneway ANOVA; **Mann-Whitney U test.
Statistical interpretation of SF-36 SFC during the rehabilitation treatment for same CIRS-G severity degree.
| Evaluated groups | CIRS-G (degree) | Musculoskeletal impairment | Neurological impairment | Cognitive impairment | |||
|---|---|---|---|---|---|---|---|
| N | (F value) † | N | (F value) † | N | (F value) † | ||
| Groups 1-4 | 0 | 62 | 87.168** | 147 | 151.851** | 109 | 168.584** |
| 1 | 75 | 44.313** | 17 | 10.828** | 40 | 36.919** | |
| 2 | 37 | 39.071** | 14 | 8.196** | 26 | 15.219** | |
| 3 | 29 | 17.889** | 17 | 12.685** | 18 | 10.672** | |
| 4 | 0 | - | 8 | 4.704** | 10 | 3.344* | |
Oneway ANOVA; *p<0.05; **p<0.01.
Correlations of SF-36 SFC values in defined severity degree of CIRS-G regarding the time of observation.
| CIRS-G (degree) | Evaluated groups | Musculoskeletal impairment† | Neurological impairment† | Cognitive impairment† |
|---|---|---|---|---|
| 0 | Groups 1/2 | 0.783 | 0.820 | 0.794 |
| Groups 1/3 | 0.622 | 0.742 | 0.696 | |
| Groups 1/4 | 0.581 | 0.696 | 0.633 | |
| Groups 2/3 | 0.765 | 0.895 | 0.862 | |
| Groups 2/4 | 0.765 | 0.843 | 0.789 | |
| 1 | Groups 1/2 | 0.867 | 0.858 | 0.846 |
| Groups 1/3 | 0.837 | 0.837 | 0.735 | |
| Groups 1/4 | 0.789 | 0.765 | 0.653 | |
| Groups 2/3 | 0.919 | 0.903 | 0.904 | |
| Groups 2/4 | 0.877 | 0.766 | 0.814 | |
| 2 | Groups 1/2 | 0.796 | 0.919 | 0.786 |
| Groups 1/3 | 0.740 | 0.785 | 0.801 | |
| Groups 1/4 | 0.655 | 0.683 | 0.791 | |
| Groups 2/3 | 0.903 | 0.905 | 0.936 | |
| Groups 2/4 | 0.828 | 0.826 | 0.864 | |
| 3 | Groups 1/2 | 0.876 | 0.816 | 0.800 |
| Groups 1/3 | 0.849 | 0.792 | 0.826 | |
| Groups 1/4 | 0.849 | 0.715 | 0.712 | |
| Groups 2/3 | 0.892 | 0.820 | 0.765 | |
| Groups 2/4 | 0.825 | 0.776 | 0.746 | |
| 4 | Groups 1/2 | - | 0.851 | 0.912 |
| Groups 1/3 | - | 0.830 | 0.946 | |
| Groups 1/4 | - | 0.646 | 0.924 | |
| Groups 2/3 | - | 0.715 | 0.868 | |
| Groups 2/4 | - | 0.646 | 0.843 |
Pearson correlation coefficient.
Statistical interpretation of SF-36 SFC values changes in different time of observation for separate CIRS-G parameters regarding severity degree.
| SF-36 SFC | Musculoskeletal impairment | Neurological impairment | Cognitive impairment | ||||
|---|---|---|---|---|---|---|---|
| F value † | η2 (%) | F value † | η2 (%) | F value † | η2 (%) | ||
| Group 1 | 0.498 | 0.75 | 3.434* | 6.49 | 8.465** | 14.60 | |
| Group 2 | 1.642 | 2.42 | 4.150** | 7.74 | 9.374** | 15.92 | |
| Group 3 | 1.487 | 2.19 | 4.568** | 8.45 | 14.718** | 22.92 | |
| Group 4 | 3.165* | 4.55 | 6.956** | 12.32 | 18.498** | 27.20 | |
Oneway ANOVA; *p<0.05; **p<0.01.